Government and Espionage Delusions in Major Neurocognitive Disorders and Delirium

Introduction: The Internal Architecture of Persecution

The intersection of cognitive decline and persecutory delusions represents one of the most clinically complex and emotionally devastating phenomena in geriatric psychiatry and neurology. As neurodegenerative processes dismantle the brain’s capacity for memory retrieval, sensory processing, and reality testing, affected individuals frequently construct elaborate, paranoid narratives to explain their increasingly fragmented reality1. Often, these narratives manifest as profound delusions of espionage, government surveillance, theft, and interpersonal replacement. The resulting clinical picture mirrors an internal "architecture of persecution." In sociological and geopolitical contexts, an architecture of persecution involves an interconnected system of state surveillance, the criminalization of ordinary behavior, the stripping of individual agency, and the deliberate "othering" of vulnerable populations to maintain control4. In the context of cognitive decline, the degenerating brain builds a psychological architecture of persecution to compensate for the terrifying loss of internal cognitive control, synthesizing disjointed sensory and cognitive failures into a rigid, systematized narrative of external threat2. This comprehensive comparative clinical report provides an exhaustive analysis of government and espionage delusions across major neurocognitive disorders and acute delirium. It delineates current diagnostic terminologies under the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and the International Classification of Diseases, 11th Revision (ICD-11). Furthermore, the analysis systematically distinguishes chronic or progressive neurocognitive illness from acute, fluctuating delirious states, exploring the precise neurobiological and cognitive drivers of specific persecutory claims. Critical attention is given to the differentiation of systematized delusions from fleeting confusional misinterpretations, the absolute necessity of screening for acute physiological precipitants using established models, and the imperative to rule out factual elder abuse and financial exploitation. Finally, the report outlines comprehensive nonpharmacological and pharmacological management strategies, highlighting the severe, disorder-specific medication risks that dictate modern geriatric psychiatric care.

Diagnostic Frameworks: DSM-5-TR and ICD-11 Nomenclature

The diagnostic classification of cognitive impairment has evolved significantly over recent decades to emphasize the severity of functional decline and the specific etiological drivers of the underlying pathology. Both the DSM-5-TR and ICD-11 have moved away from the umbrella term "dementia" as the sole primary diagnostic label, favoring nuanced terminologies that better capture the acquired, neurodegenerative nature of these deficits across the human lifespan. Under the DSM-5-TR, the term "Major Neurocognitive Disorder" (MND) requires evidence of a significant cognitive decline from a previous level of performance in one or more cognitive domains. These domains include complex attention, executive function, learning and memory, language, perceptual-motor function, or social cognition9. This decline must be documented by standardized neuropsychological testing or, in its absence, a quantified clinical assessment. Crucially, to meet the threshold for Major Neurocognitive Disorder—as opposed to Mild Neurocognitive Disorder—these cognitive deficits must be severe enough to interfere with independence in everyday activities. At a minimum, this requires the patient to need assistance with complex instrumental activities of daily living, such as managing medications or paying bills9. The DSM-5-TR also introduced specifiers for behavioral disturbances, allowing clinicians to formally diagnose an MND "with behavioral disturbance" if the cognitive decline is accompanied by clinically significant psychotic symptoms, mood disturbances, agitation, or apathy10. The ICD-11 maintains a conceptually parallel framework but retains the traditional term "Dementia" (Block 6D80) for conditions characterized by a marked impairment in two or more cognitive domains. According to the ICD-11, this impairment must be severe enough to cause significant disruption in personal, family, social, educational, or occupational functioning11. For milder presentations, the ICD-11 utilizes the diagnosis of "Mild Neurocognitive Disorder" (6D71), characterized by mild impairment in one or more domains that does not significantly interfere with independent functioning, though the individual may require compensatory strategies to maintain everyday activities11. Both diagnostic manuals strictly require that the deficits represent an acquired decline from a previously attained level of functioning and are not exclusively attributable to another mental disorder, such as late-onset schizophrenia, bipolar disorder, or major depressive disorder10. Delirium, conversely, is distinctly separated from major neurocognitive disorders in both diagnostic manuals due to its acute onset, fluctuating course, and distinct pathophysiological mechanisms. The DSM-5-TR criteria for delirium mandate a primary disturbance in attention, defined as a reduced ability to direct, focus, sustain, and shift attention, coupled with a disturbance in awareness, manifesting as a reduced orientation to the environment14. This disturbance must develop over a very short period, typically hours to a few days, represent a clear change from baseline attention and awareness, and tend to fluctuate in severity during the course of a single day14. An additional disturbance in cognition—such as a profound memory deficit, disorientation, language impairment, visuospatial deficit, or perceptual disturbance—must also be present. Furthermore, there must be evidence from the patient's history, physical examination, or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, exposure to a toxin, or multiple complex etiologies14. The ICD-11 aligns seamlessly with these clinical criteria, defining delirium (6D70) as a disturbance of attention, orientation, and awareness that develops within a short time frame. It presents as significant confusion or global neurocognitive impairment, with transient symptoms that fluctuate depending on the underlying causal condition or metabolic etiology18.

Etiologies of Major Neurocognitive Disorders and Psychotic Manifestations

The clinical presentation of government and espionage delusions is not uniform across all neurocognitive patients; it varies significantly based on the underlying neuropathology and specific regional brain atrophy of the neurocognitive disorder. Alzheimer Disease (AD) is the most common etiology of major neurocognitive disorder, accounting for a vast majority of cases in the aging population. It is characterized histopathologically by the accumulation of extracellular beta-amyloid plaques and intracellular neurofibrillary tangles composed of hyperphosphorylated tau proteins22. AD typically presents with prominent early deficits in episodic memory, learning, and spatial navigation10. Psychotic symptoms in AD, including delusions of theft or abandonment, tend to emerge in the moderate to severe stages of the illness. Neuroimaging and pathophysiological hypotheses suggest that delusions in AD are strongly correlated with frontal lobe hypometabolism, severe deficits in fronto-subcortical functions (the "hypofrontality model"), and extensive degeneration of the cholinergic basal forebrain projection neurons22. Furthermore, muscarinic acetylcholine receptor density has been shown to increase in the frontal cortex of AD patients presenting with psychotic symptoms, indicating a compensatory, yet dysfunctional, neurochemical response22. Dementia with Lewy Bodies (DLB) represents a distinct neurodegenerative entity, classified as an alpha-synucleinopathy and characterized by the abnormal intracellular accumulation of Lewy bodies and Lewy neurites, particularly in the brainstem, limbic system, and neocortex23. The core clinical features of DLB include pronounced fluctuating cognition with marked variations in attention and alertness, recurrent and well-formed visual hallucinations, and spontaneous motor features of parkinsonism (bradykinesia, resting tremor, rigidity)24. Severe neuroleptic sensitivity and rapid eye movement (REM) sleep behavior disorder are heavily weighted suggestive features for diagnosis25. Systematized delusions, including phantom boarder syndrome and Capgras delusion, are significantly more prevalent in DLB than in AD27. Up to 75% of patients with DLB experience hallucinations, and more than 50% suffer from complex delusions, largely driven by profound dopaminergic and acetylcholinergic neurochemical imbalances and severe occipitotemporal pathology23. Parkinson Disease Dementia (PDD) shares an identical histopathological profile with DLB, driven by alpha-synuclein aggregation, but is distinguished clinically by the temporal sequence of symptom onset, known as the "one-year rule." In PDD, well-established motor parkinsonism precedes the onset of dementia by at least twelve months. Conversely, in DLB, the dementia precedes or occurs concurrently with the onset of parkinsonism25. Psychosis is highly common in the later stages of PDD, presenting a complex management challenge as it is frequently exacerbated by the necessary dopaminergic replacement therapies used to manage the patient's motor symptoms27. Vascular Neurocognitive Disorder (VND) results from diverse cerebrovascular diseases, including large vessel strokes, multiple lacunar infarcts, or chronic microvascular ischemic changes manifesting as periventricular white matter hyperintensities10. The cognitive profile of VND is typically characterized by prominent executive dysfunction, significantly slowed processing speed, and a stepwise or fluctuating pattern of decline rather than the smooth, insidious progression seen in AD31. When lesions affect the right hemisphere or disrupt fronto-subcortical circuits, patients with VND are highly susceptible to developing paranoid delusions and misidentification syndromes32. Frontotemporal Degeneration (FTD) encompasses a spectrum of behavioral and language-variant disorders driven by the selective degeneration of the frontal and temporal lobes. The behavioral variant of FTD (bvFTD) presents with profound early executive dysfunction, social disinhibition, apathy, dietary changes, and a striking loss of empathy10. While classic paranoid delusions are less common in FTD than in DLB, significant genetic and clinical overlap exists between certain early-onset FTD presentations and schizophrenia-spectrum disorders. Genetic mutations in the progranulin gene (GRN), microtubule-associated protein tau (MAPT), or C9orf72 can produce clinical pictures featuring prominent psychotic symptoms years before the formal dementia diagnosis is established34.

Cognitive and Perceptual Drivers of Suspicion

The emergence of espionage, surveillance, and persecutory delusions is not arbitrary; rather, it is a direct and logical consequence of specific, localized cognitive and perceptual failures. As the brain loses its fundamental ability to accurately process, encode, and interpret the external world, it attempts to impose a semblance of order on a chaotic, frightening reality, often resulting in complex paranoid misinterpretations2.

Memory Loss, Confabulation, and the Delusion of Theft

Profound short-term memory impairment (anterograde amnesia), particularly in the early to moderate stages of AD, leaves individuals completely unable to recall where they placed everyday items. When a patient cannot locate their wallet, house keys, glasses, or specific items of clothing, the underlying cognitive deficit prevents them from accurately attributing the loss to their own memory failure. Recognizing one's own profound cognitive decline is deeply threatening to the ego; therefore, the brain generates a defensive, external explanation: the item was purposefully stolen by a malicious actor1. This paranoid worry frequently leads the patient to actively hide their remaining possessions in highly unusual places—such as placing jewelry in the freezer or a wallet under a mattress—in a desperate attempt to protect them. This compensatory behavior inevitably exacerbates the problem, as the novel hiding places are quickly forgotten, reinforcing the entrenched delusion of persistent, systemic theft1. Confabulation, the unconscious and non-deceptive production of fabricated, distorted, or misinterpreted memories, serves to fill these terrifying mnemonic voids. Because of severe impairments in source monitoring and reality filtering, patients may confidently recount a highly detailed, fabricated narrative of neighbors, hospital personnel, or caregivers entering their home at night to steal their property35. To the patient, these confabulated narratives carry the full emotional weight and certainty of authentic memories, rendering logical confrontation completely ineffective and counterproductive35.

Impaired Recognition and Delusional Misidentification Syndromes

Neurocognitive disorders, particularly DLB and right-hemisphere dominant VND, frequently feature severe visuospatial and perceptual impairments. These localized cortical deficits directly contribute to Delusional Misidentification Syndromes (DMS), which are robustly associated with claims of espionage, infiltration, and surveillance27. Capgras Syndrome is a deeply distressing psychiatric disorder in which the patient holds a fixed, unshakeable belief that a familiar person, usually a spouse or primary caregiver, has been entirely replaced by an identical-looking impostor30. Neurobiological models and advanced functional imaging suggest that Capgras arises from a structural or functional disconnection between the brain's facial recognition systems and its emotional processing centers. Specifically, the dual-route model of facial recognition posits that the ventral visual stream (involving the fusiform gyrus) processes the physical features of a face for identification, while a separate dorsal affective pathway (involving the amygdala and retrosplenial cortex) generates the autonomic emotional response to a familiar, loved face36. In Capgras delusion, the patient successfully recognizes the visual features of their spouse (the ventral stream is intact), but they experience absolutely no emotional warmth, autonomic arousal, or familiarity (the dorsal stream is damaged or disconnected)41. Faced with the paradox of seeing their spouse but feeling as though they are looking at a stranger, the brain concludes logically—within its damaged neuroanatomical framework—that the person must be a highly sophisticated replica, a spy, or a malevolent impostor41. Phantom Boarder Syndrome occurs when the patient believes that uninvited individuals are secretly residing in their home despite all evidence to the contrary32. While these "boarders" may sometimes be perceived as benign guests, they are frequently viewed as hostile spies, government intruders, or agents conducting covert surveillance28. This syndrome is highly prevalent in DLB and Parkinson's disease, and is strongly associated with visuo-amygdaloid pathway dysfunction and severe right temporo-parietal hypometabolism32. Research into "presence hallucinations"—the visceral sensation that someone is nearby when the room is empty—suggests that abnormal sensorimotor processing and integration in the degenerating brain are the foundational mechanisms driving the delusion of the phantom boarder44.

Executive Dysfunction and Visual Hallucinations

Executive dysfunction impairs the prefrontal cortex's ability to engage in reality testing, inhibiting the capacity to evaluate the plausibility of a spontaneous thought and reject it if it is irrational20. When severe executive dysfunction is combined with the complex visual hallucinations that are a core diagnostic feature of DLB, the clinical results are profound. Patients with DLB frequently see well-formed, highly detailed, and persistent images of people, animals, or complex machines26. Due to frontal lobe hypometabolism, the patient entirely lacks the executive capacity to recognize the hallucination as a manifestation of their disease. Consequently, hallucinatory figures standing in the living room are interpreted not as visual tricks, but as literal government spies or agents monitoring the home.

The Architecture of Persecution: Specific Delusional Themes

The content of delusions in neurocognitive disorders is not random; it frequently clusters around distinct themes of systemic surveillance, unremitting persecution, and exploitation2. This clinical presentation deeply mirrors an actual "architecture of persecution"4. In historical, sociological, and geopolitical contexts, a state-engineered architecture of persecution involves an interconnected, inescapable system of constant state surveillance, the criminalization of ordinary behavior, the total stripping of individual agency, and the "othering" of a population to maintain absolute control and instill chronic fear4. In the context of severe cognitive decline, the patient inadvertently constructs a psychological architecture of persecution to synthesize their disjointed sensory failures, memory lapses, and terrifying loss of autonomy into a unified, explanatory narrative.

Government Agents and Covert Spies

Patients may develop rigid, fixed beliefs that they are the primary targets of highly sophisticated intelligence operations involving the FBI, the CIA, foreign operatives, or localized police forces47. Due to profound deficits in source monitoring, an external piece of information—such as a television news broadcast discussing global government surveillance, or a radio segment on political espionage—may be erroneously internalized as a direct, personal threat20. The inability to integrate environmental context or judge probability leads patients to interpret entirely routine, benign events—such as a mail carrier altering their walking route, a utility worker checking a neighborhood meter, or a car parked slightly longer than usual on the street—as undeniable evidence of coordinated espionage.

Medical Equipment as Surveillance Technology

In both acute inpatient hospital settings and home healthcare environments, unfamiliar and complex medical equipment is frequently incorporated into the paranoid architecture of the patient's delusion. Continuous Positive Airway Pressure (CPAP) machines, intravenous (IV) infusion pumps, holter monitors, pulse oximeters, and even hearing aids may be perceived as covert wiretaps, GPS tracking devices, or high-definition cameras installed by hostile forces to monitor their every move28. The presence of flashing LED lights, digital displays, rhythmic beeping, and trailing wires provides the necessary raw sensory input. This input is then grossly misinterpreted by the failing occipitotemporal and frontal cortices as evidence of an invasive, inescapable surveillance apparatus constructed by their persecutors.

Caregivers and Neighbors as Conspirators

Because professional caregivers, spouses, and immediate neighbors are the most proximate individuals in the patient's shrinking world, they frequently become the primary suspects and central antagonists in the delusion of persecution1. Caregivers who are simply assisting with vulnerable activities of daily living—such as bathing, dressing, managing daily medications, or organizing finances—are accused of physical abuse, systemic theft, or attempting to poison the patient's food1. Within the rigid architecture of the patient's delusion, the caregiver is absolutely not viewed as an exhausted, loving spouse or a dedicated medical professional; rather, they are seen as a covert operative, an infiltrator, or a Capgras impostor actively orchestrating the patient's ultimate demise35.

Differentiating Systematized Delusions from Fleeting Confusion

A highly critical diagnostic step in geriatric psychiatry is differentiating the fundamental nature of the persecutory claim based on its structural integrity and temporal stability.

Chronic and Progressive Neurocognitive Illness

In major neurocognitive disorders, particularly in the later stages of DLB and in Very-Late-Onset Schizophrenia-Like Psychosis (VLOSLP), delusions tend to be deeply systematized8. A systematized delusion is a highly organized, complex, and persistent false belief. The patient creates a logically consistent (albeit entirely false) narrative that accounts for various details and objections25. For example, a patient with DLB might claim that the government has replaced their spouse with a highly trained spy specifically to monitor their bank accounts. When challenged, the patient will cite specific, woven "evidence" to support the claim, such as a slightly altered facial expression, a misplaced checkbook, or a phone call that the spouse took in another room30. This systematized delusion remains rigidly fixed over weeks, months, or even years, and is completely impervious to rational counter-argument, logic, or objective proof8.

Acute, Fluctuating Delirious States

In stark contrast, the psychotic features of acute delirium present as fleeting, poorly organized, and highly fragmented misinterpretations of the environment20. Because delirium is fundamentally a global disorder of attention, arousal, and network connectivity14, the delirious patient lacks the cognitive capacity to sustain a complex, systematized narrative. A delirious patient might momentarily perceive a phlebotomist as an assassin, or misinterpret a blood pressure cuff as a specialized torture device20. However, minutes or hours later, as the patient's level of arousal naturally fluctuates, this specific, terrifying delusion may vanish entirely. It may be rapidly replaced by a completely different visual hallucination (such as animals in the room), or a brief period of total lucidity19. Delirious delusions are highly reactive to immediate, changing sensory input and completely lack the entrenched, architectural complexity and narrative stability seen in chronic neurocognitive illness20.

Screening for Acute Precipitants: The PINCH ME Model

When an older adult presents to a clinical setting with an acute onset or a sudden, severe exacerbation of surveillance delusions, confusion, or behavioral agitation, clinicians must immediately suspect delirium. Delirium is a medical emergency; it carries exceptionally high rates of morbidity, institutionalization, and mortality if the underlying physiological cause is not rapidly identified and aggressively treated21. The "PINCH ME" mnemonic provides a standardized, exhaustive, and widely utilized screening framework for identifying the precipitating causes of acute delirium in vulnerable populations53:

To rapidly operationalize this screening, tools such as the 4A's Test (4AT)—which formally assesses Alertness, the AMT4 (Abbreviated Mental Test 4), Attention (e.g., months of the year backwards), and Acute change or fluctuating course—should be universally deployed in emergency and inpatient settings to rapidly identify delirium before symptoms escalate21.

Differential Diagnosis: Distinguishing Psychosis, Mood, and Reality

Accurate diagnosis in geriatric psychiatry requires meticulously differentiating neurocognitive delusions from primary psychiatric disorders that arise in late life, sensory-loss phenomena, and the actual, tragic occurrence of elder abuse.

Very-Late-Onset Schizophrenia-Like Psychosis (VLOSLP)

Schizophrenia-spectrum disorders are not exclusively illnesses of young adulthood; they can and do manifest in late life. Very-Late-Onset Schizophrenia-Like Psychosis (VLOSLP) is a distinct nosological entity defined by international consensus as the onset of psychotic symptoms after the age of 6051. Unlike early-onset schizophrenia, VLOSLP is characterized by a significantly higher prevalence in females, a notable absence of severe negative symptoms (such as extreme apathy or avolition), and an absence of formal thought disorder31. The delusional content in VLOSLP is highly specific, frequently involving "partition delusions"—the fixed belief that people, substances, radiation, or forces can pass freely through solid walls, floors, or ceilings to harass the patient31. Furthermore, patients with VLOSLP often experience rich, multimodal hallucinations, encompassing visual, auditory (often accusatory or abusive human voices), tactile, and olfactory modalities29. While patients with VLOSLP exhibit mild cognitive deficits—particularly in the domains of executive function, learning, and cognitive flexibility—they do not display the profound, rapidly progressive, global neurodegenerative decline characteristic of AD or DLB, maintaining basic activities of daily living for much longer periods31.

Depression with Psychotic Features

Severe major depressive disorder in older adults can frequently present with mood-congruent psychotic features8. A profoundly depressed patient may develop a delusion that they are being monitored by the government or targeted by the police as direct retribution for perceived past sins or moral failings. The delusions in psychotic depression are deeply rooted in pervasive feelings of guilt, utter worthlessness, and somatic nihilism, which helps the clinician differentiate them from the primary perceptual and memory-driven failures of DLB or AD20.

Sensory-Loss Phenomena

Profound sensory deficits (such as advanced macular degeneration or severe presbycusis) can independently generate psychotic-like symptoms in the elderly. Charles Bonnet Syndrome involves the experience of complex, vivid visual hallucinations in individuals with severe visual impairment; however, crucially, these patients typically possess intact cognition and retain the insight that the hallucinations are not real. Similarly, profound, uncorrected deafness can lead to paranoid ideation, suspiciousness, and auditory hallucinations due to the brain's reaction to chronic auditory deprivation, a phenomenon often misattributed to a primary psychotic disorder29.

Factual Abuse, Neglect, or Financial Exploitation

A critical, non-negotiable mandate in geriatric care is to avoid the clinical trap of assuming that all accusations of theft, abuse, or surveillance made by cognitively impaired adults are merely symptoms of their disease3. Older adults with major neurocognitive disorders are highly vulnerable targets for factual financial exploitation, physical abuse, passive neglect, and willful deprivation by caregivers, family members, or opportunistic neighbors63. When a patient claims that a caregiver is stealing money, moving objects, or monitoring their activities to take their property, the clinician must objectively and thoroughly assess the situation. This involves:

1. Conducting a private, unhurried interview with the patient, isolated from the suspected caregiver, to allow them to speak freely35.
2. Evaluating objective, external evidence, such as sudden, unexplained changes in banking patterns, unpaid utility bills despite adequate financial resources, malnutrition, dehydration, or the presence of unexplained physical injuries and bruising64.
3. Carefully observing the caregiver's demeanor during clinical encounters for signs of extreme defensiveness, aggression, dismissal of the patient, or an adamant refusal to leave the patient alone during medical interviews.

If factual abuse or financial exploitation is reasonably suspected, mandatory reporting laws in almost all jurisdictions require immediate referral to Adult Protective Services (APS) or local law enforcement62. State agencies, such as the Illinois Adult Protective Services hotline, operate 24 hours a day and grant total civil and criminal immunity to healthcare providers making reports in good faith62. APS investigators possess the specialized training and legal authority to review financial records, conduct unannounced home visits, and implement protective interventions, ensuring the patient's safety before dismissing their claims as delusions63.

Fictional Comparative Vignette: Surveillance Claims in Divergent Syndromes

To deeply illustrate the critical clinical distinctions between a chronic, systematized delusion in a major neurocognitive disorder and a fleeting, hyperactive misinterpretation in acute delirium, consider the following comparative vignette. Both patients present to the emergency department making nearly identical claims of governmental surveillance, but their underlying pathology, neurobiology, and required clinical management are drastically different. Patient A: Mr. H (Dementia with Lewy Bodies \- Systematized Delusion) Mr. H is a 74-year-old male with a documented two-year history of progressive cognitive decline, recurrent, detailed visual hallucinations of animals in his yard, and spontaneous rigidity. He is brought to the geriatric clinic by his wife of fifty years. During the interview, Mr. H calmly but with absolute conviction asserts that his wife has been secretly replaced by an undercover federal agent (Capgras syndrome) and that his Continuous Positive Airway Pressure (CPAP) machine has been covertly modified into an audio-surveillance wiretap by the government30. His delusion is highly structured and systematized; he points to a specific, rhythmic blinking LED light on the CPAP machine as undeniable "proof" of real-time data transmission25. Despite his wife’s obvious emotional distress, Mr. H’s attention is largely intact during the interview, and his level of consciousness is alert and oriented to the clinic setting26. A comprehensive physical examination and metabolic workup reveal no acute abnormalities. Furthermore, an independent APS review of his finances and living situation completely rules out any actual exploitation or abuse. Mr. H’s presentation represents a chronic, systematized delusion driven by the severe visuospatial, facial processing, and executive deficits inherent to his underlying DLB23. Patient B: Mr. M (Vascular Neurocognitive Disorder \+ Acute Delirium \- Fleeting Misinterpretation) Mr. M is a 78-year-old male with a known history of moderate Vascular Neurocognitive Disorder following multiple lacunar infarcts, usually requiring assistance only with his finances. He is admitted to the hospital for a suspected severe, sepsis-inducing urinary tract infection (UTI). Upon admission, his baseline cognition deteriorates precipitously. He is profoundly lethargic, highly distractible, and completely unable to sustain a logical conversation or perform the AMT419. When a floor nurse attempts to adjust his intravenous (IV) pole to administer antibiotics, Mr. M suddenly becomes hyperactive and agitated, shouting that the hospital staff are foreign spies attempting to extract his memories using the IV pump, which he misidentifies as a high-tech surveillance camera20. However, thirty minutes later, Mr. M falls into a deep, somnolent sleep; upon waking, his arousal shifts again. He has forgotten the "spy" accusation entirely but begins frantically picking at non-existent insects on his blanket20. His presentation is characteristic of an acute, mixed-type delirium (triggered by the severe systemic infection and unfamiliar environment), characterized by fleeting, disorganized misinterpretations, visual illusions, and profound attentional deficits52.

Comprehensive Management Strategies

The treatment of government, espionage, and surveillance delusions requires a highly nuanced, multidisciplinary balance of behavioral intervention, environmental optimization, caregiver psychoeducation, and, when strictly necessary and legally documented, careful pharmacological therapy.

Nonpharmacological Management and Environmental Modification

Nonpharmacological interventions are universally considered the gold standard and absolute first-line approach for managing the behavioral and psychological symptoms of dementia35. Validation and de-escalation are the core tenets of communication. Clinicians and caregivers must never argue with the patient, attempt to aggressively disprove the delusion, or rely on stark logic2. Because delusions are defined as fixed false beliefs, presenting objective, logical evidence (e.g., unscrewing the CPAP machine to show the patient that it contains no microphone) will only increase the patient's severe agitation and reinforce their paranoid belief that the caregiver is actively part of the conspiracy2. Instead, the caregiver should validate the patient's underlying emotional distress ("It must be absolutely terrifying to feel like you are constantly being watched in your own home") and gently redirect their focus to a comforting, familiar, and highly engaging activity1. Environmental modification serves to simplify the patient's world, reducing the overwhelming sensory burden on a failing brain3. Removing unnecessary clutter, establishing strict, consistent locations for important everyday items (keys, wallets, purses) with exact backup duplicates ready, and ensuring adequate ambient lighting can minimize the misinterpretation of shadows or the terrifying belief that a misplaced item was stolen by a spy1. If a specific object—such as a large mirror triggering mirror-sign misidentification, or a complex piece of electronics—constantly triggers a delusion, it should be permanently covered or removed from the environment33. Caregiver support is equally critical. Delusional misidentification syndromes, particularly Capgras, inflict severe, highly specific emotional trauma on spouses and children, leading to exceptionally high rates of clinical depression, isolation, and burnout30. Providing targeted psychoeducation to caregivers—helping them deeply understand that the accusation is a purely neurological symptom of a damaged brain pathway, not a reflection of reality or a failure of their caregiving—is essential for preserving the caregiver's mental health and preventing early institutionalization of the patient2.

Pharmacological Management and Severe Disorder-Specific Risks

When delusions cause severe, unremitting distress, present a direct risk of physical harm to the patient or their caregivers, and completely fail to respond to optimized nonpharmacological interventions, pharmacological management may be cautiously considered2. However, the use of antipsychotic medications in older adults with major neurocognitive disorders carries profound, life-threatening risks that dictate modern prescribing practices.

FDA Boxed Warnings and Excess Mortality

In 2005, following a highly publicized meta-analysis of 17 randomized, placebo-controlled trials, the U.S. Food and Drug Administration (FDA) issued a Boxed Warning (black box warning) for all atypical (second-generation) antipsychotics, including risperidone, olanzapine, and quetiapine67. The analysis revealed a stark reality: elderly patients with dementia-related psychosis treated with atypical antipsychotics had a mortality risk 1.6 to 1.7 times higher than those receiving a placebo56. Over a typical 10-week trial, the rate of death in drug-treated patients was approximately 4.5%, compared to 2.6% in the placebo group. The primary causes of this excess death were cardiovascular events (heart failure, sudden cardiac death) and infectious etiologies (pneumonia, notably aspiration pneumonia secondary to drug-induced dysphagia and sedation)56. In 2008, this Boxed Warning was officially extended to include all typical (first-generation) antipsychotics, such as haloperidol. Large observational studies firmly indicated that older conventional agents carried equal, if not significantly higher, risks of mortality and severe cerebrovascular adverse events (stroke, transient ischemic attack) compared to their atypical counterparts72. Recent advanced meta-analyses continue to confirm these risks, demonstrating significantly elevated incidence rates of death, acute kidney injury, and venous thromboembolism in antipsychotic users versus matched non-users73.

Disorder-Specific Risks: Neuroleptic Sensitivity in DLB

While antipsychotics carry severe risks across all dementia subtypes, their administration in Dementia with Lewy Bodies (DLB) and Parkinson Disease Dementia (PDD) is exceptionally dangerous and frequently catastrophic. Approximately 30% to 50% of patients with DLB exhibit severe neuroleptic sensitivity23. Exposure to traditional dopamine receptor antagonists, and even to many newer atypical agents, can precipitate a sudden, massive, and highly irreversible worsening of parkinsonism. This manifests as profound rigidity, heavy sedation, severely impaired swallowing (guaranteeing aspiration), autonomic collapse, and potentially fatal Neuroleptic Malignant Syndrome (NMS)55. The heightened dopaminergic denervation hypersensitivity inherent to DLB pathology renders the use of typical antipsychotics absolutely contraindicated22.

Safer Pharmacological Alternatives

Given the severe limitations and mortality risks of traditional antipsychotics, alternative, receptor-specific pharmacological strategies must be utilized:

• Pimavanserin: Pimavanserin represents a paradigm shift in managing neurodegenerative psychosis. It is a highly selective serotonin inverse agonist/antagonist specifically targeting the 5-HT2A receptor, with negligible binding affinity for dopaminergic, adrenergic, histaminergic, or muscarinic receptors77. Because it entirely avoids blocking dopamine receptors, it does not worsen motor symptoms or trigger neuroleptic sensitivity in alpha-synucleinopathies75. The FDA has approved pimavanserin specifically for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis75. Extensive subgroup analyses from the pivotal Phase 3 HARMONY trial demonstrate its robust efficacy in significantly reducing the risk of psychosis relapse (Hazard Ratio 0.03) in patients with PDD and DLB, completely without causing the cognitive or motor deterioration seen with classic neuroleptics77.
• Cholinesterase Inhibitors: Acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine) are the established standard of care for cognitive symptoms in AD and LBD76. Furthermore, restoring central cholinergic tone in the brain can significantly improve severe neuropsychiatric symptoms. Clinical case series demonstrate that cholinesterase inhibitors can effectively reduce complex visual hallucinations and terrifying misidentification syndromes like Capgras and Phantom Boarder in DLB, offering a vastly safer initial pharmacological approach than resorting to dangerous neuroleptics37.

Conclusion

Delusions of government espionage, covert surveillance, and systemic persecution in older adults represent a deeply complex interplay of progressive neurodegenerative pathology, acute physiological disruption, and the human mind's desperate attempt to rationalize profound cognitive deficits. Accurately distinguishing the deeply systematized, chronic delusions of Major Neurocognitive Disorders—particularly Dementia with Lewy Bodies—from the acute, highly fluctuating misinterpretations of delirium is essential for accurate diagnosis and the rapid triaging of life-saving care. Clinicians must rigorously and systematically screen for underlying medical precipitants using comprehensive frameworks like the PINCH ME model, and they must remain eternally vigilant in assessing for factual elder abuse or financial exploitation before comfortably dismissing a patient's claims as purely delusional. Management relies fundamentally on optimizing the patient's environment, providing robust support for traumatized caregivers, and utilizing validation techniques to soothe emotional distress. When pharmacological intervention becomes absolutely necessary to prevent harm, it must be executed with extreme, evidence-based caution. Clinicians must navigate the stark realities of FDA Boxed Warnings for antipsychotic-induced mortality and the life-threatening risk of neuroleptic sensitivity in specific alpha-synucleinopathies, favoring targeted therapies like pimavanserin or cholinesterase inhibitors. Through a highly nuanced, interdisciplinary approach, healthcare providers can effectively mitigate the profound distress caused by these internal architectures of persecution, ultimately safeguarding the health, safety, and dignity of the aging patient.

Works cited

1. Delusions, paranoia and dementia | Alzheimer's Society, https://www.alzheimers.org.uk/about-dementia/stages-and-symptoms/delusions
2. Suspicion & Delusions | Alzheimer's Association, https://www.alz.org/help-support/caregiving/stages-behaviors/suspicions-delusions
3. False beliefs and delusions in dementia, https://www.dementiauk.org/information-and-support/health-advice/false-beliefs-and-delusions-in-dementia/
4. Judging “Privileged” Jews: Holocaust Ethics, Representation, and the “Grey Zone” | Jewish Book Council, https://www.jewishbookcouncil.org/book/judging-privileged-jews-holocaust-ethics-representation-and-the-grey-zone
5. From Sporadic Hostility to Normalised Persecution: A year of systematic persecution of Christians in India | CJP, https://cjp.org.in/from-sporadic-hostility-to-normalised-persecution-a-year-of-systematic-persecution-of-christians-in-india/
6. IFS Insights: A State-Engineered Architecture of Persecution \- Norwegian Armed Forces, https://www.forsvaret.no/en/research/popular-science/ifs-insights-a-state-engineered-architecture-of-persecution
7. The Tragic Destiny of LGBT in Iran | European Journal of Humanities and Social Sciences, https://eu-opensci.org/index.php/ejsocial/article/view/18612
8. Understanding Delusions in Psychiatry | PDF \- Scribd, https://www.scribd.com/document/702185709/understanding-delusions-2
9. DSM-5 and Neurocognitive Disorders | Journal of the American Academy of Psychiatry and the Law, https://jaapl.org/content/42/2/159
10. Major Neurocognitive Disorder \- PsychDB, https://www.psychdb.com/cl/2-major-neurocog-disorder
11. Mild neurocognitive disorder \- WHO-FIC Foundation, https://icd.who.int/dev11/f/en?\escaped\fragment\_=/http%253A%252F%252Fid.who.int%252Ficd%252Fentity%252F195531803
12. Neurocognitive disorders \- ICD-11 MMS \- Find-A-Code, https://www.findacode.com/icd-11/block-213458094.html
13. The phenotype of delirium based on a close reading of diagnostic criteria \- PMC \- NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC10763520/
14. DSM-5 criteria for delirium \- Primary Care Notebook, https://primarycarenotebook.com/pages/geriatric-medicine/dsm-5-criteria-for-delirium
15. DSM-5-TR Delirium Diagnostic Criteria \- CARLAT PUBLISHING, https://www.thecarlatreport.com/ext/resources/2023/03/31/CHPR\AprilMayJun2023\DSM-5\Diagnostic\_Criteria.pdf
16. Delirium \- Therapedia \- Theravive Counseling, https://www.theravive.com/therapedia/delirium
17. The DSM-5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4177077/
18. ICD-11 Criteria for Neurocognitive Disorders (BlockL1‑6D7) \- MRCPsych UK, https://www.mrcpsych.uk/2022/05/icd-11-criteria-for-neurocognitive.html
19. Delirium \- Symptoms and causes \- Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/delirium/symptoms-causes/syc-20371386
20. Delirium \- Neupsy Key, https://neupsykey.com/delirium-3/
21. Delirium Screening – DRAT & 4AT, https://www.swslhd.health.nsw.gov.au/EODS/pdf/Resources/4AT%20Notes%20pages.pdf
22. Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship?, https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2021.808724/full
23. Dementia with lewy bodies \- diagnosis and treatment \- Swiss Medical Weekly, https://smw.ch/index.php/smw/article/download/244/241
24. Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC6987529/
25. Diagnosis and management of dementia with Lewy bodies \- Perelman School of Medicine at the University of Pennsylvania, https://www.med.upenn.edu/digitalneuropathologylab/assets/user-content/documents/educational-resources/diagnosis-and-management-of-dementia-with-lewy-bodies-third-report-of-the-dlb-consortium.pdf
26. Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions \- Journal of Movement Disorders, https://www.e-jmd.org/journal/view.php?number=267
27. Presentation and Management of Psychosis in Parkinson's Disease and Dementia With Lewy Bodies | American Journal of Psychiatry, https://psychiatryonline.org/doi/10.1176/appi.ajp.2007.07040715
28. Lewy Body Dementia \- \- Practical Neurology, https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/lewy-body-dementia-1/31536/
29. Clinical Features of Auditory Hallucinations in Patients With Dementia With Lewy Bodies, https://www.psychiatrist.com/jcp/auditory-hallucinations-in-dementia-with-lewy-bodies/
30. Capgras syndrome in Dementia with Lewy Bodies \- PMC \- NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4004517/
31. Very Late-Onset Schizophrenia-Like Psychosis: A Case Report and Critical Literature Review \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC10326410/
32. Delusional Misidentification Syndrome: Phantom Boarder Syndrome Presenting With Intact General Cognition and Functional Brain Imaging Evidence of Bilateral Posterior and Orbitofrontal Hypometabolism | The Journal of Neuropsychiatry and Clinical Neurosciences \- Psychiatry Online, https://psychiatryonline.org/doi/10.1176/appi.neuropsych.18080185
33. (PDF) Cognitive neuroscience of delusions in aging \- ResearchGate, https://www.researchgate.net/publication/24398889\Cognitive\neuroscience\of\delusions\in\_aging
34. Schizophrenia and dementia across the lifespan: epidemiological links, cognitive trajectories, and the pathophysiological interplay \- Frontiers, https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1779076/full
35. False Accusations in Dementia Care: Understanding, Responding, and Preserving Trust, https://www.nccdp.org/false-accusations-in-dementia-care/
36. Capgras Syndrome: Insights into Criminal Behavior \- European Society of Medicine, https://esmed.org/capgras-syndrome-insights-into-criminal-behavior/
37. Capgras Syndrome in LBD: Causes and Treatment Options | Lewy Body Dementia Association (LBDA), https://lbda.org/capgras-syndrome-in-lewy-body-dementias-lbd-associated-with-anxiety-and-hallucinations
38. Capgras Syndrome in DLB Associated with Anxiety and Hallucinations, https://lbda.org/capgras-syndrome-in-dlb-associated-with-anxiety-and-hallucinations
39. Capgras Syndrome: What It Is, Causes, Symptoms & Treatment \- Cleveland Clinic, https://my.clevelandclinic.org/health/diseases/capgras-syndrome
40. Brain Metabolic Dysfunction in Capgras Delusion During Alzheimer's Disease: A Positron Emission Tomography Study \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC10852786/
41. Capgras Syndrome \- StatPearls \- NCBI Bookshelf \- NIH, https://www.ncbi.nlm.nih.gov/books/NBK570557/
42. What do we know about delusional misidentification disorders? A focus on Capgras syndrome, https://www.jneuropsychiatry.org/peer-review/what-do-we-know-about-delusional-misidentification-disorders-a-focus-on-capgras-syndrome-neuropsychiatry.pdf
43. Finding the imposter: brain connectivity of lesions causing delusional misidentifications, https://pmc.ncbi.nlm.nih.gov/articles/PMC5278302/
44. Phantom Boarder Relates to Experimentally‐Induced Presence Hallucinations in Parkinson's Disease \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC10105112/
45. Phantom Boarder Relates to Experimentally-Induced Presence Hallucinations in Parkinson's Disease \- PubMed, https://pubmed.ncbi.nlm.nih.gov/37070043/
46. Capgras-like visual decomposition in Lewy body dementia with therapeutic response to donepezil \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC4277662/
47. Patient Management Exercise Schizophrenia \- Psychiatry Online, https://psychiatryonline.org/doi/pdf/10.1176/foc.6.2.foc185
48. Patient Management Exercise Schizophrenia | Focus \- Psychiatry Online, https://www.psychiatryonline.org/doi/10.1176/foc.6.2.foc185
49. Treatment details (neuropsychiatry) \- 北野病院, https://www.kitano-hp.or.jp/english/section/seisin/cure
50. Capgras Syndrome in Dementia: Are You a Pretender or the 'Real Mary'? \- Michigan Medicine, https://www.michiganmedicine.org/health-lab/capgras-syndrome-dementia-are-you-pretender-or-real-mary
51. Late-Onset Psychosis \- Psychiatry Investigation, https://www.psychiatryinvestigation.org/m/journal/view.php?number=779
52. Delirium Awareness: Bridging the Gap Between Screening and Clinical Practice, https://www.bgs.org.uk/delirium-awareness-bridging-the-gap-between-screening-and-clinical-practice
53. pinch-me-cards.pdf, https://www.gloucestershire.gov.uk/media/nvji5dar/pinch-me-cards.pdf
54. Delirium \- Geriatric Primary Care, https://www.cgakit.com/p-2-delirium
55. Delirium Assessment OSCE — 4AT, Causes, and Management, https://talkosce.co.uk/blog/delirium-assessment-osce
56. Beyond the Black Box: What is The Role for Antipsychotics in Dementia? \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC2641030/
57. Delirium-assessment-tool-4AT.pdf \- Health Innovation Manchester, https://healthinnovationmanchester.com/wp-content/uploads/2018/10/Delirium-assessment-tool-4AT.pdf
58. (PDF) Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus \- ResearchGate, https://www.researchgate.net/publication/232953895\Late-onset\schizophrenia\and\very-late-onset\schizophrenia-like\psychosis\An\international\_consensus
59. Assessing symptoms profile and correlates of very late-onset schizophrenia-like psychosis (VLOSLP) \- Scirp.org., https://www.scirp.org/journal/paperinformation?paperid=27944
60. The Neuropsychological Profile and Phenomenology of Late Onset Psychosis: A Cross-sectional Study on the Differential Diagnosis of Very-Late-Onset Schizophrenia-Like Psychosis, Dementia with Lewy Bodies and Alzheimer's Type Dementia with Psychosis \- PubMed, https://pubmed.ncbi.nlm.nih.gov/29635309/
61. Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International Consensus \- Psychiatry Online, https://psychiatryonline.org/doi/10.1176/appi.ajp.157.2.172
62. Adult Protective Services \- AgeOptions, https://www.ageoptions.org/resources/adult-protective-services/
63. Adult Protective Services (APS) \- Illinois Department on Aging, https://ilaging.illinois.gov/protectionadvocacy/abuse.html
64. Adult Protective Services : What We Do \- Solutions for Care, https://solutionsforcare.org/what-we-do/adult-protective-services.html
65. Adult Protective Services, https://www.metrofamily.org/aps/
66. Delirium | Johns Hopkins Medicine, https://www.hopkinsmedicine.org/health/conditions-and-diseases/delirium
67. Mortality and Antipsychotic Use in Dementia-related Behavioral Disorders \- Duke-Margolis Institute for Health Policy, https://healthpolicy.duke.edu/sites/default/files/2024-12/Discussion%20Guide%20Mortality%20and%20Antipsychotic%20Use%20in%20Dementia-related%20Behavioral%20Disorders%20Virtual%20Public%20Workshop\_1.pdf
68. What You Need to Know About Capgras Syndrome \- Lewy Body Dementia Resource Center, https://lewybodyresourcecenter.org/what-you-need-to-know-about-capgras-syndrome/
69. FDA warns about using antipsychotic drugs for dementia \- PMC \- NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC556368/
70. FDA Warns of Excess Mortality to Elderly With Antipsychotics | MedPage Today, https://www.medpagetoday.com/neurology/alzheimersdisease/870
71. 20-592/S049 21-086/S028 21-253/S033 \- accessdata.fda.gov, https://www.accessdata.fda.gov/drugsatfda\_docs/nda/2008/020592orig1s049.pdf
72. FDA Extends Black-Box Warning to All Antipsychotics | Psychiatric News \- Psychiatry Online, https://psychiatryonline.org/doi/10.1176/pn.43.14.0001
73. Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study | The BMJ, https://www.bmj.com/content/385/bmj-2023-076268
74. Mortality and Antipsychotic Use in Dementia-Related Behavioral Disorders \- Margolis Institute for Health Policy, https://healthpolicy.duke.edu/sites/default/files/2025-03/Meeting%20Summary\_Mortality%20and%20Antipsychotic%20Use%20in%20Dementia-Related%20Behavioral%20Disorders.docx.pdf
75. Neuroleptic Sensitivity in Dementia with Lewy Body and Use of Pimavanserin in an Inpatient Setting: A Case Report \- PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC9619381/
76. Treatment Guidance and Medication Considerations in LBD | Lewy Body Dementia Association (LBDA), https://lbda.org/treatment
77. • In this post hoc subgroup analysis of patients with Lewy body dementia in the HARMONY trial, treatment with pimavanserin red \- Acadia Pharmaceuticals, https://acadia.com/en-us/pdf/healthcare-professionals/scientific-publications/congress-materials/PSG\2024\045\\PDD\Combined\Subgroups\_Final.pdf
78. Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series \- PubMed, https://pubmed.ncbi.nlm.nih.gov/37775968/
79. Safety and efficacy of pimavanserin in patients with Lewy body dementia experiencing dementia-related psychosis in the HARMONY study \- PubMed, https://pubmed.ncbi.nlm.nih.gov/41286676/
80. New Research Supports Nuplazid (Pimavanserin) Use in Parkinson's Disease Dementia, https://lbda.org/new-research-supports-nuplazid-pimavanserin-use-in-parkinsons-disease-dementia
81. HARMONY Trial Shows Pimavanserin Reduces Relapse in Dementia‑Related Psychosis, https://lbda.org/positive-results-for-the-harmony-clinical-trial-of-pimavanserin-in-dementia-related-psychosis
82. Delusional Misidentification Syndrome with Response to Donepezil and Behavioral Intervention in a Patient with Dementia \- Walsh Medical Media, https://www.walshmedicalmedia.com/open-access/delusional-misidentification-syndrome-with-response-to-donepezil-and-behavioral-intervention-in-a-patient-with-dementia-2329-8847-1000181.pdf